In vitro inhibition of human cytomegalovirus replication by desferrioxamine

This publication has 16 references indexed in Scilit:

• 2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (1110U81) potently inhibits human cytomegalovirus replication and potentiates the antiviral effects of ganciclovir
  Antimicrobial Agents and Chemotherapy, 1993
• Monitoring of ganciclovir sensitivity of multiple human cytomegalovirus strains coinfecting blood of an AIDS patient by an immediate-early antigen plaque assay
  Antiviral Research, 1992
• Herpes and human ribonucleotide reductases: Inhibition by 2-acetylpyridine 5-[(2-chloroanilino)-thiocarbonyl]-thiocarbonohydrazone (348U87)
  Biochemical Pharmacology, 1991
• Herpes simplex virus type 1 ribonucleotide reductase: Selective and synergistic inactivation by a1110u and its iron complex
  Biochemical Pharmacology, 1990
• Neutralization of Epstein-Barr virus-induced ribonucleotide reductase with antibody to the major restricted early antigen polypeptide
  Virology, 1989
• Pharmacokinetics and renal elimination of desferrioxamine and ferrioxamine in healthy subjects and patients with haemochromatosis.
  British Journal of Clinical Pharmacology, 1987
• Impairment of nucleotide metabolism by iron-chelating deferoxamine
  Biochemical Pharmacology, 1987
• THE MANAGEMENT OF IRON CHELATION THERAPY
  British Journal of Haematology, 1983
• Ribonucleotide Reductase Induced by Herpes Simplex Virus has a Virus-specified Constituent
  Journal of General Virology, 1983
• Effect of Iron Deficiency and Desferrioxamine on DNA Synthesis in Human Cells
  British Journal of Haematology, 1976